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Abstract
The realization of long–term human organ preservation will have groundbreaking effects on the
current practice of transplantation. Herein we present a novel technique based on sub–zero non–
freezing tissue preservation and extracorporeal machine perfusion that allows transplantation of rat
livers preserved for up to 4 days, thereby tripling the viable preservation duration.
Introduction
With 119,000 patients waiting to receive a donor organ today, the field of transplantation is
facing a serious donor shortage crisis. The introduction of University of Wisconsin (UW)
solution by Belzer and Southard in 19831 represented a pivotal breakthrough in hypothermic
organ preservation (HP). It substantially extended the viable preservation time of donor
organs2,3, which led to the first intercontinental kidney transplantation and provided a major
thrust that led to the current success of solid organ transplantation. To this day, donor livers
are preserved in ice–cold UW solution, which offers a maximum cold preservation time of
6–12 h. Extension of this storage time, to a hypothetical 24 h, would allow a larger donation
territory, reduce pressure on procedural logistics, and optimize recipient preparation.
Together, such advances could contribute towards intercontinental liver sharing, which
would greatly reduce the donor shortage4.
Cryopreservation has been successful in several cell and tissue types5 and investigated to
achieve long–term solid organ storage. However, success remains elusive due to adverse
processes brought on by these extreme temperature and processes necessary to reach them,
which can disrupt tissues at the cellular level6,7. Experimental endeavors to achieve viable
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tlong–term preservation of whole organs range from vitrification at −196 °C4,8,9 to
supercooling (sub–zero non–freezing) at 0 °C to −5 °C10–16 but have yet to yield substantial
success, especially demonstrated by transplantation. These challenges are augmented when
preserving liver tissue, due to the delicate hepatic anatomy comprising multiple cell types
with variable preservation properties and functions: for instance it has been shown that
frozen rat livers could be transplanted with apparently healthy hepatocytes and a functioning
biliary system, but would fail due the impaired vasculature and endothelial cell death17.
Machine perfusion (organ support through extra–corporeal artificial circulation) is one
technique to have shown a substantial advantage over conventional hypothermic storage,
and has since been implemented into routine clinical practice for kidneys18,19. While this
method could hypothetically extend viable preservation times, with few exceptions20, most
studies focus on alleviation of the donor shortage through recovery of (warm ischemic)
organs that would otherwise have been discarded19,21,22.
In this report we present a novel method for extended liver storage that combines
supercooling (SC) and machine perfusion. Our central hypothesis was that since HP
primarily works through deceleration of cellular metabolism at lowered temperatures,
supercooling would allow further extension of the viable preservation time. However,
supercooling poses several challenges, a) ice nucleation can occur during storage and needs
to be avoided; b) extended storage at this temperature along with the rewarming process can
result in irreversible plasma membrane injuries23,24 and eventual osmotic imbalance that
follows; and c) cold temperatures and subsequent rewarming, in general, increase
susceptibility of cells to produce free radicals while reducing their natural defense ability
against such damaging reactive species25. This particularly affects the hepatic sinusoid,
which is the functional unit of the liver that directly interacts with the exterior milieu26. The
sinusoidal endothelial cells (SECs) are extremely sensitive to hypothermia, which causes
cellular swelling and disruption of the microcirculation27,28. Moreover, extension of the
storage duration is likely to exacerbate the ischemia reperfusion injury observed. Therefore
we sought to create a novel protocol and media to dramatically extend liver preservation
duration as described below.
Study Design
For HP, the UW preservation solution has been a remarkable success. However for the
purposes of supercooling we sought to supplement the solution to reduce cold–induced
membrane injury. As traditional freezing point depressors such polyglycols are toxic and
may lead to issues in clinical translation, we avoided their use at least in these first studies.
Based on a literature survey, we chose PEG–35kD (5%), which is shown to protect the
epithelial cell membrane29,30 and has been previously used as a colloid for liver machine
perfusion as well31.
Since PEG is limited to extracellular media, we also considered employing an intracellular
cytoprotectant that is nontoxic and usable for the liver: Inspired by freeze–tolerant species
that produce high concentrations of glucose as a cryoprotectant32, a non–metabolizable
glucose derivative (3-O-methyl-D-glucose, 3–OMG) was tested as an intracellular
protectant. 3–OMG is taken up naturally by hepatocytes through the GLUT–1 and −2
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ttransporters, is non–metabolizable therefore accumulates internally, and is non–toxic and
used in clinical glucose uptake studies33,34; it was therefore chosen over typical
preservatives such as glycerol. Our group has previously shown that primary hepatocytes in
vitro show superior post–thaw quality when cryopreserved with 3–OMG33 although to our
knowledge this study is the first in testing 3–OMG for supercooling.
Finally, to counter the effects of extended ischemia we employed machine perfusion, which
has been demonstrated to alleviate hypothermic endothelial injury28, reinitialize metabolic
activity, replenish ATP, and mechanically prime the vasculature for reperfusion19,35–37. We
chose subnormothermic machine perfusion (SNMP) based on our success in using this
method for recovering 1 h warm ischemic rat livers for transplantation38–40.
The method, as displayed in Fig. 1a entails storage of rat livers for 3 and 4 days at −6 °C,
more than thrice the maximum preservation time achievable by HP, and testing by
transplantation. The protocol (for comprehensive details, see Supplementary Material)
includes the following: First, prior to supercooling, we used SNMP with modified Williams
medium E to load isolated rat livers with 0.2 M 3–OMG. The dosage and loading
characteristics of 3–OMG were derived from in vitro experiments using isolated rat
hepatocytes33. Next, we cooled the organ during SNMP to 4 °C (1 °C min−1), and flushed it
with 10 mL, 4 °C UW solution containing 5% PEG–35kD (UW–PEG). The liver was
submerged in 75 mL of 4 °C UW–PEG. We then placed the liver inside a controlled–rate
freezer, and lowered the temperature further to −6 °C (1 °C 10 min−1), initiating the
supercooling phase that was maintained for 72 h (n=6) or 96 h (n=12). Following
supercooling we gradually increased the temperature to 4 °C, after which we flushed the
liver with room temperature, oxygenated Williams E medium and subjected it to SNMP (3
h, 21 °C), previously shown in our laboratory to recover ischemic rat livers for
transplantation38, while we recorded multiple viability parameters. We finally transplanted
the liver orthotopically38. We obtained blood samples for up to a month and monitored the
recipient for survival and clinical signs of cirrhosis for up to 3 months.
Results
Post–transplantation
Three–month survival in the 72 h SC group was 100%, while no survival was achieved after
an equal duration of HP (Table 1). This result triples the achievable storage duration by HP,
which is limited to 24 h in rat transplants. Increasing the duration of supercooling to 96 h
resulted in 58% survival, which is comparable to 48 h of HP. Negative controls in which
either the SNMP loading phase, 3–OMG and PEG supplementation were individually
omitted succumbed within 6 days (Table 1), whereas negative controls omitting the SNMP
recovery succumbed within 1 h post–transplantation. Despite a prolonged post–surgical
recovery period and increased postoperative cellular damage parameters up to 14 days post–
surgery (Fig. 1b), recipients of 72 h and 96 h SC livers thrived past 3 months post–
transplantation without any signs of organ failure. Post–operative blood levels of albumin,
bilirubin, alkaline phosphatase, and blood urea normalized within 1 month post–op, and
coagulation times were normal in all animals (data not shown). There were no signs (either
histological, hematological, or morphological) of postoperative cholangiopathy up to 3
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tmonths post–surgery in any of the animals except one (72 h SC group), which developed a
large biloma 18–20 days post–surgery, likely due to blockage of the bile duct stent.
SNMP recovery phase
SNMP enables real–time evaluation of metabolic and vascular parameters. Tissue ATP
levels, that dropped to approximately 10% (51.5 ± 45.7 pmol mg protein−1) of fresh levels
(457.2 ± 77.9 pmol mg protein−1) after 96 h supercooling, were replenished to ca. 50% after
recovery SNMP (197.5 ± 39.0 pmol mg protein−1). While supercooled livers produced less
bile than fresh livers subjected to SNMP (Fig. 2a), bile production was substantial compared
to an equal duration of HP where bile production was minimal. Additionally, a significant
difference in bile production was observed between livers that led to survival and those that
did not (p=0.0017). Increased hepatic resistance during SNMP also correlated strongly with
transplant survival in the 96 h SC group (p<0.0001, Fig. 2b), suggesting that both bile
production and a mean resistance <15 cm H2O min mL−1 during SNMP recovery could be
predictive of liver viability. Aminotransferase output was increased from fresh livers in both
SC groups (Fig. 2c). Oxygen consumption during SNMP was not different between groups.
Within livers in the 96 h SC, a significantly higher oxygen uptake was observed in livers
that survived (p<0.0001; Fig. 2d). Liver weight did not increase significantly during
supercooling (+2.6%, p>0.05) or during recovery SNMP (+5.6%, p>0.05) and there were no
significant differences between groups. H&E staining and TEM of supercooled livers
showed normal hepatic anatomy in all slides (Fig. 2e). Post–supercooling samples contained
intracellular accumulation of glycogen–like intracellular matter, which may be internalized
3–OMG. In the post–transplantation specimens, hepatocyte crowding and biliary hyperplasia
were observed, consistent with typical hepatocellular regeneration after liver transplantation.
Discussion
Supercooling is the first preservation technique capable of producing transplantable livers
after 4 days of storage. The protocol comprises four essential components: 1) supercooling;
2) 3–OMG; 3) PEG–35kD; and 4) machine perfusion loading of 3–OMG and for recovering
viability and energy stores prior to transplantation. We have shown that each of these
components is individually required to achieve viable supercooling preservation in our
model, as evidenced by long–term recipient survival.
We show here that clinically acceptable survival is limited to 72 h of storage, dropping
considerably to 58% if the storage time is extended to 96 h. As extensive screening of
different additives or variations in protocol is still ongoing, additional improvements may be
achieved from future experimentation. In addition, continued investigation of the individual
protocol components should provide a better understanding of the mechanisms at play.
During SNMP recovery of the 96 h SC group, we retrospectively observed segregation of
survivor and nonsurvivor recipients in terms of hepatic resistance, after just 30 min of
SNMP. Hence, observation of elevated hepatic resistance after supercooling can be
interpreted as a marker for hepatic damage, which is similar to that observed in non–
supercooling SNMP studies. This conclusion would suggest the sinusoid, the crucial
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tinterface between the liver and the outside milieu, as the element of major focus for future
work.
As a proof–of–concept small animal study, our current model has limitations and requires
validation in a large animal model. The size, robustness, and preservation properties of
human hepatocytes and livers differ from rodent, presenting translational challenges not
only regarding preservation biology, but also engineering and cost. For example, our model
is not suited to investigate ischemic cholangiopathy, as this type of complication does not
mimic clinical situations in rat models. Therefore, while histological analysis, morphological
examination, and hematology did not reveal any indication of severe cholangiopathy in
supercooled livers, this must be examined further using a higher order species model that
utilizes clinically relevant biliary anastomosis that includes reconstruction of the hepatic
artery. A second size–related issue is that in a human liver the amount of liquid volume
subject to freezing will be much larger and therefore the probability of freezing may
increase; this may require tuning the preservation media or supercooling process.
As determine feasibility, we only focused on fresh livers in this work. However a major use
for a superior preservation protocol would be enhancing the utilization of marginal donor
organs, such as ischemically injured livers donated after cardiac death. Therefore a
profitable next step is to test and optimize the protocol described here to enable
transplantation of such currently untransplantable livers.
The achievement of long–term survival after supercooling preservation, with more than a
threefold increase in the currently achievable preservation time, signifies the potential of this
novel modality. The eventual goal of extending the viable preservation time of human
organs will contribute towards global organ sharing, increased organ availability, and
reduction of overall cost.
Methods
Brief description of the experimental protocol
The liver was recovered from inbred male Lewis rats as described in detail previously41,42
(see Liver Recovery below for surgical details). Livers were subjected to subnormothermic
machine perfusion (SNMP) at room temperature38,43 (see below for detailed description),
through the portal vein, for 60 min; the PV cuff attached to a 20G catheter in the perfusion
system. The perfusate consisted of supplemented Williams medium E (Sigma-Aldrich, St
Louis, MO, USA) and contained the non–metabolizable glucose 3–OMG (Sigma-Aldrich, St
Louis, MO, USA). After 60 min of loading, the temperature of the perfusate was lowered
gradually (1 °C min−1) to 4 °C under continuous perfusion. Then, the liver was flushed
briefly with 20 mL of UW solution containing 5% 35kD–PEG, transferred to a sterile bag
filled with the same solution, and moved to a controlled–rate freezer. The temperature was
lowered to −6 °C (1 °C 10 min−1) and preservation was continued for up to 4 days. The
temperature was then raised to 4 °C (1 °C 10 min−1), and the liver was flushed with
supplemented with Williams E medium, and subjected to 3 h of recovery SNMP (see
Supercooling Procedure below for more operational details). During SNMP, measurements
included liver weight, blood gas analysis, perfusate AST and ALT, bile flow, and hepatic
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tvascular resistance. The liver was then transplanted orthotopically in a recipient animal38.
We collected and analyzed blood, weighed the recipients and assessed the clinical condition
for 30 days. All animals were observed for up to 3 months clinically.
Liver Recovery—Inbred male Lewis rats weighing 250 to 300 g (Charles River
Laboratories, Boston, MA, USA) were used for transplantation. The animals were
maintained in accordance with National Research Council guidelines, and the experimental
protocols were approved by the IACUC at Massachusetts General Hospital (Boston, MA,
USA). After dissection of the ligaments surrounding the liver, the intrahepatic inferior vena
cava (IHIVC) and portal vein (PV) were elongated by dissecting their distributive veins
(right renal and adrenal veins, lumbar venous plexus, gastroduodenal and splenic veins). The
left diaphragmatic vein was ligated. The hepatic artery was ligated and cut. The common
bile duct was cannulated for bile collection and dissected. The portal vein was cannulated
and the liver was perfused with 10 mL, 21 °C oxygenated Williams medium E, excised from
its recess and transferred to the subnormothermic machine perfusion (SNMP) system. The
portal vein was cuffed using a modified 22G intravenous catheter.
Subnormothermic Machine Perfusion (SNMP)—The liver was flushed in situ with
room temperature Williams Medium E and immediately connected to the SNMP system.
Machine perfusion took place in a circuit comprising a perfusion chamber, a peristaltic
pump, a membrane oxygenator, and a bubble trap. Details can be found elsewhere38,43.
Temperature within the system equilibrated to room temperature at 21 °C and was not
controlled otherwise. The perfusate volume was 350 mL, consisting of Williams Medium E
supplemented with insulin (2 U L−1 Humulin; Eli Lilly & Co, Indianapolis, IN, USA),
penicillin (40,000 U L−1) / streptomycin (40,000 μg L−1; Gibco/Invitrogen, Camarillo, CA,
USA), L–glutamine (0.292 g L−1; Gibco/Invitrogen), hydrocortisone (10 mg L−1 Solu-
Cortef; Pharmacia & Upjohn/Pfizer, New York, NY, USA) and heparin (1000 U L−1; APP
pharmaceuticals, Schaumberg, IL, USA) (note that during preloading this was supplemented
with 3–OMG and insulin as noted below; otherwise the loading and recovery perfusions are
identical). The oxygenator was gassed with a mixture of 95% O2 and 5% CO2. Flow–rate
was started at 8.0 mL min−1, and adjusted according to the portal resistance, which was kept
between 0.5 and 1.5 cmH2O min mL−1. Aspartate aminotransferase and alanine
aminotransferase were measured using an Infinity AST (GOT) and ALT liquid stable kit
(Cellomics/Thermo Electron, Pittsburgh, PA, USA). Every 30 min PV inflow and IVC
outflow were analyzed using a using a blood gas analyzer (Rapidlab 845 blood gas analyzer,
Bayer). Bile was collected continually via a cannula inserted into the bile duct, which
drained into a collection tube.
Supercooling Procedure
Loading phase: Livers were subjected to 1 h of SNMP using oxygenated Williams E
supplemented with 750 U L−1 insulin and 0.2 M 3-O-methyl-D-glucose. The final
osmolality of the solution was 290–310 mOsm L−1. The loading time was based partly on in
vitro work with 3–OMG33, as well as preliminary trials conducted with our system (data not
shown).
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tSupercooling phase: The SNMP system is equipped with jacketed components (perfusion
chamber, oxygenator, bubble trap, and perfusion reservoir) that allow circulation of
antifreeze through the system on a separate circuit, enabling exact temperature regulation
during machine perfusion. Liver temperature was measured using a thermocouple inserted
into the suprahepatic inferior vena cava. After the 60 min 3–OMG loading phase, the
temperature was reduced (1 °C min−1) to 4 °C. The liver was flushed with 10 mL ice–cold
UW solution supplemented with polyethylene glycol (35kD PEG, 5% W/V; Sigma-Aldrich)
(UW–PEG) and transferred to a sterile bag filled with 4 °C UW–PEG. To prevent
thermocouple–induced ice nucleation, the temperature calibrations were performed in
separate experiments, however; independent temperature monitoring of the antifreeze and
UW–PEG solution was performed throughout. The liver was flushed with 10 mL UW–PEG
prior to supercooling to ensure distribution of the preservation solution to the hepatic
sinusoid. As the flush is under hypothermic conditions, washout of 3–OMG should be at a
minimum, while failure to remove the SNMP perfusate from the liver would likely result in
ice formation during supercooling. The sterile bag was sealed and was immersed in ice–cold
antifreeze, transferred to a controlled rate freezer, and cooled to −6 °C (1 °C 10 min−1, final
intrahepatic temperature: between −5.5 and −6 °C); this is the lowest temperature at which
ice formation could be prevented reliably over a period of four days in our system. The liver
was preserved for 72–96 h avoiding perturbations and temperature variation.
Recovery phase: The temperature was raised to 4 °C (1 °C min−1), the liver was flushed
with Williams E medium, and SNMP recovery was performed for 3 h. The recipient was
prepared for surgery during perfusion recovery. Perfusion was stopped, the liver
disconnected, and flushed with room temperature Lactated Ringer’s solution. The liver was
orthotopically transplanted into a weight–matched recipient Lewis rat as described
elsewhere1. Please note that we specifically avoided the cold flush during the transplant
procedure.
Post–Transplantation Analysis—Tail–vein blood samples were taken from
transplantation recipients hourly after the procedure for 3 h, then daily for 7 days, and finally
after 30 days. The blood samples were analyzed using a Piccolo Blood Chemistry Analyzer
(metabolic panel; Abaxis, Union City, CA). At 30 days post–transplant, the liver was
recovered for histology.
Histology—Samples from dedicated livers were processed for light and electron
microscopy (EM). For light microscopy samples were fixed in 10% buffered formalin until
further processing and stained using heamatoxylin and eosin (H&E). For EM samples were
fixed in Karnofsky’s solution.
Statistics—Sample sizes were selected based on a power analysis based on past transplant
experiments with similar variances. There was no blinding or randomization in selection of
animals; however experiments were standardized (inbred Lewis rats of the same age and
weight, transplantations performed at the same time of day by the same microsurgeon
(T.A.B). Two–way (repeated measures) analysis of variance (ANOVA) was performed at
α=0.05, with post–hoc Bonferroni correction for comparisons between different preservation
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tgroups over time. An unpaired student’s t–test was performed for ATP recovery and bile
production between groups. A log–rank (Mantel–Cox) test was performed to compare
survival curves. Normality assumption and distributions within groups were tested where
appropriate.
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Transplantation of supercooled livers (a) Schematic temperature profile of the supercooling
protocol. (b) Post-transplantation trends in transaminase output (shown are all recipients,
including those that did not survive past day 1). (c) 30-day survival post-transplantation for
selected groups.
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tFigure 2.
Subnormothermic machine perfusion recovery and histology (a) Bile production per gram of
liver during SNMP recovery phase. Survivors and nonsurvivors are separately represented
for the 96 h supercooling group. * Indicates a statistically significant difference between
survivors and nonsurvivors (p<0.01). (b) Hepatic resistance during SNMP recovery. (c)
Hepatic transaminase levels in media during the SNMP recovery. (d) Oxygen consumption
during SNMP recovery. (e) TOP: Transmission electron microscopy images (1500x initial
magnification) of different stages of the supercooling protocol; fresh liver tissue, post-
supercooling liver, post-SNMP recovery liver, and 30 days post-transplantation. The post-
supercooling image contains a close-up of the glycogen-like structure observed in these
specimens. BOTTOM: Light microscopy images of H&E stained tissue samples at
corresponding stages of study.
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